Endotoxin Testing Comports With QbD as Part of Risk Management Plan: Guidance
Drugmakers keen to infuse quality by design (QbD) concepts into regulatory filings are urged to fold endotoxin testing into their overall risk-management plans, an FDA draft guidance states.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.